Renhe Pharmacy Co., Ltd.
000650.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.36B
Close$
$7.15
39.4% upside
Current Fair Value
39.4% upsideUndervalued by 39.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $7.36 Billion |
|---|---|
| Enterprise Value | $6.42 Billion |
| Dividend Yield | $0.15 (2.87%) |
| Earnings per Share | $0.28 |
| Beta | 0.37 |
| Outstanding Shares | 1,374,198,184 |
Return
| Return on Equity | 6.06% |
|---|---|
| Return on Assets | 4.83% |
| Return on Invested Capital | 8.63% |
Valuation & Multiples
| P/E Ratio | 18.61 |
|---|---|
| PEG | 92.19 |
| Price to Sales | 2.57 |
| Price to Book Ratio | 1.03 |
| Enterprise Value to Revenue | 1.76 |
| Enterprise Value to EBIT | 10.28 |
| Enterprise Value to Net Income | 16 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 26, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
October 27, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Renhe Pharmacy Co., Ltd.
4,923 employees
CEO: Wujun Huang Renhe Pharmacy Co., Ltd. is a pharmaceutical enterprise engaged in the manufacturing and distribution of a wide array of products. Its diverse portfolio includes both traditional Chinese and modern Western medicines, their essential raw ...